Prospect Financial Services LLC acquired a new stake in Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 255,150 shares of the company’s stock, valued at approximately $977,000. Acurx Pharmaceuticals comprises 1.0% of Prospect Financial Services LLC’s holdings, […]
Frazier Life Sciences Management L.P. cut its holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) by 75.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 397,483 shares of the company’s stock after selling 1,192,448 shares during the quarter. Frazier Life Sciences Management L.P.’s […]
Seven Eight Capital LP grew its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 15.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 66,207 shares of the biopharmaceutical company’s stock after buying an additional 8,908 shares during the period. Seven Eight […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CEO Christopher Gibson sold 50,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $8.42, for a total transaction of $421,000.00. Following the completion of the sale, the chief executive officer now owns […]
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) was the target of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 204,400 shares, a decrease of 11.1% from the April 30th total of 229,900 shares. Based on an average daily volume of 159,600 shares, […]